Drug Cartels News | Drug Cartels News – Drug Cartels Information

Alzheimer’s

03/07/2018 / By Ethan Huff

Big Pharma’s contradictory JUNK SCIENCE: Merck pulls “promising” Alzheimer’s drug from trials the same day Cleveland Clinic hails its success

Testing on what drug giant Merck & Co. had tried to claim was going to be a breakthrough new remedy for Alzheimer’s disease came to a sudden halt recently after it was determined that the drug in question actually doesn’t work at all. But interestingly enough, the trial’s cessation occurred on the very same day […]

12/03/2017 / By Tracey Watson

Treatment for Alzheimer’s can kill faster than the disease: Antipsychotic drugs found to increase risk of death

An estimated 5.5 million Americans are currently living with Alzheimer’s disease. The symptoms of this debilitating illness include memory loss, agitation, mood swings, impaired judgment, difficulty handling money effectively, struggling with normal everyday tasks, confusion, misplacing things and difficulty communicating, among many others. The incredible strain this illness places on families and caregivers of those […]

10/15/2017 / By Ethan Huff

Pharmacist who shuttles carloads of pharma drugs to Congress admits they’re senile, brain-damaged patients who “might not even remember what happened yesterday”

Many of the nation’s top lawmakers appear to be pharmaceutical drug addicts who rely on a steady stream of pharma pills being covertly shipped into them daily at Capitol Hill via a local pharmacy in D.C. known as Grubb’s. It’s a quaint little place that a recent article published by STATNews.com featured in an almost […]

09/05/2017 / By Rhonda Johansson

Antidepressants found to drastically increase head injuries among Alzheimer’s patients

A nationwide cohort study conducted in Finland found that antidepressants increased the risk of head and traumatic brain injuries among patients with Alzheimer’s disease. While antidepressants have been linked to an increased risk of falling, no study thus far researched a possible connection between the drug and brain injuries in community-dwelling patients with Alzheimer’s. Researchers […]

08/01/2017 / By Ethan Huff

Big Pharma’s Alzheimer’s gold rush: 35 new drugs to hit the market in the next few years as the drug cartels cash in on cognitive decline

It’s no big secret that the pharmaceutical industry isn’t at all concerned with trying to advance the cause of improving public health by identifying the causes of age-related cognitive decline. But it sure is banking on raking in a windfall of profits trying to treating it, with the latest figures showing that pharmaceutical companies as […]

1 of 1